Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Ago Research Gmbh

Clinical trials sponsored by Ago Research Gmbh, explained in plain language.

Trials to join now! 2
Sort by
  • New drug combo could boost ovarian cancer surgery success

    Disease control Recruiting now

    This study is for people with advanced ovarian cancer who are scheduled for surgery. It tests whether taking a drug called olaparib alone or with another drug called durvalumab for a short time before surgery is safe and practical. The goal is to see if this approach can be done …

    Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control

    Last updated May 15, 2026 12:01 UTC

  • New drug combo offers hope for Hard-to-Treat vulvar cancer

    Disease control Recruiting now

    This study tests whether two drugs, pembrolizumab and lenvatinib, can shrink tumors in people with vulvar cancer that has come back, spread, or cannot be removed by surgery or radiation. About 42 participants will receive the drug combination. The goal is to see how many patients…

    Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control

    Last updated May 15, 2026 11:56 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space